Phosphorylation of proteins involved in activity-dependent forms of synaptic plasticity is altered in hippocampal slices maintained in vitro.

Department of Physiology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Journal of Neurochemistry (Impact Factor: 4.24). 01/2005; 91(6):1344-57. DOI: 10.1111/j.1471-4159.2004.02815.x
Source: PubMed

ABSTRACT The acute hippocampal slice preparation has been widely used to study the cellular mechanisms underlying activity-dependent forms of synaptic plasticity such as long-term potentiation (LTP) and long-term depression (LTD). Although protein phosphorylation has a key role in LTP and LTD, little is known about how protein phosphorylation might be altered in hippocampal slices maintained in vitro. To begin to address this issue, we examined the effects of slicing and in vitro maintenance on phosphorylation of six proteins involved in LTP and/or LTD. We found that AMPA receptor (AMPAR) glutamate receptor 1 (GluR1) subunits are persistently dephosphorylated in slices maintained in vitro for up to 8 h. alpha calcium/calmodulin-dependent kinase II (alphaCamKII) was also strongly dephosphorylated during the first 3 h in vitro but thereafter recovered to near control levels. In contrast, phosphorylation of the extracellular signal-regulated kinase ERK2, the ERK kinase MEK, proline-rich tyrosine kinase 2 (Pyk2), and Src family kinases was significantly, but transiently, increased. Electrophysiological experiments revealed that the induction of LTD by low-frequency synaptic stimulation was sensitive to time in vitro. These findings indicate that phosphorylation of proteins involved in N-methyl-D-aspartate (NMDA) receptor-dependent forms of synaptic plasticity is altered in hippocampal slices and suggest that some of these changes can significantly influence the induction of LTD.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Long-term potentiation (LTP) is a type of synaptic plasticity characterized by an increase in synaptic strength and believed to be involved in memory encoding. LTP elicited in the CA1 region of acute hippocampal slices has been extensively studied. However the molecular mechanisms underlying the maintenance phase of this phenomenon are still poorly understood. This could be partly due to the various experimental conditions used by different laboratories. Indeed, the maintenance phase of LTP is strongly dependent on external parameters like oxygenation, temperature and humidity. It is also dependent on internal parameters like orientation of the slicing plane and slice viability after dissection. The optimization of all these parameters enables the induction of a very reproducible and very stable long-term potentiation. This methodology offers the possibility to further explore the molecular mechanisms involved in the stable increase in synaptic strength in hippocampal slices. It also highlights the importance of experimental conditions in in vitro investigation of neurophysiological phenomena.
    Journal of Visualized Experiments 01/2013; DOI:10.3791/50483
  • [Show abstract] [Hide abstract]
    ABSTRACT: In pyramidal cells, the induction of spike-dependent plasticity (STDP) follows a simple Hebbian rule in which the order of presynaptic and postsynaptic firing dictates the induction of LTP or LTD. In contrast, cortical fast spiking (FS) interneurons, which control the rate and timing of pyramidal cell firing, reportedly express timing-dependent LTD, but not timing-dependent LTP. Because a mismatch in STDP rules could impact the maintenance of the excitation/inhibition balance, we examined the neuromodulation of STDP in FS cells of mouse visual cortex. We found that stimulation of adrenergic receptors enables the induction of Hebbian bidirectional STDP in FS cells in a manner consistent with a pull-push mechanism previously characterized in pyramidal cells. However, in pyramidal cells, STDP induction depends on NMDA receptors, whereas in FS cells it depends on mGluR5 receptors. We propose that neuromodulators control the polarity of STDP in different synapses in the same manner, and independently of the induction mechanism, by acting downstream in the plasticity cascade. By doing so, neuromodulators may allow coordinated plastic changes in FS and pyramidal cells.
    The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 08/2013; 33(32):13171-8. DOI:10.1523/JNEUROSCI.5741-12.2013 · 6.75 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Technological limitations have restricted the ability to determine chronic drug effects on synaptic function from in vitro preparations. In earlier studies, the extracellular recording duration was limited to less than 10 h and only a distinct population of neurons was examined. To address these limitations, we used organotypic hippocampal slice cultures integrated with planar multi-electrode arrays (MEA-OHSC), which permitted within-slice comparisons and examination of long-term changes across multiple populations of neurons. Long-term potentiation (LTP) is a widely accepted measure of synaptic plasticity, and is believed to be a cellular mechanism underlying learning and memory. Amyloid-β protein (Aβ) is a 40–42 amino acid peptide that is the primary element of senile plaques, a pathological hallmark of Alzheimer's disease (AD). In contrast to earlier studies, MEA-OHSCs allowed for long-term administration of Aβ1–42 to more closely model the chronic nature of AD pathogenesis. Prior to Aβ1–42 exposure, the CA1 region displayed robust potentiation, but afterwards the ability to induce LTP was nearly absent. Spatial analysis illustrated, for the first time, the substantial area of LTP induction, and clearly showed the global loss of this plasticity after long-term Aβ exposure. The MEA-OHSC model characterized here presents an ideal platform for examining the effects chronic exposure of a bioactive compound can have on a cellular correlate of memory. This model could also be used to screen potential therapeutics that may influence synaptic activity. Drug Dev Res 68:84–93, 2007. Published 2007 Wiley-Liss, Inc.; Canadian Crown Copyright
    Drug Development Research 03/2007; 68(2):84 - 93. DOI:10.1002/ddr.20170 · 0.73 Impact Factor

Full-text (2 Sources)

1 Download
Available from
Mar 6, 2015